🚀 VC round data is live in beta, check it out!

Biomind Labs Valuation Multiples

Discover revenue and EBITDA valuation multiples for Biomind Labs and similar public comparables like Aton, ExpreS2ion Biotech, Pila Pharma, Vivesto and more.

Biomind Labs Overview

About Biomind Labs

Biomind Labs Inc is a biotech research and development company aimed at transforming biomedical sciences knowledge from natural psychotropic plants into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. Biomind is developing pharmaceutical sole and combined formulations of the main natural psychedelic molecules with the objective of identifying novel pharmaceutical compounds for treating a wide range of therapeutic indications.


Founded

2020

HQ

Uruguay

Employees

3

Financials (FY)

Revenue:
EBITDA: ($219K)

EV

$7M

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Biomind Labs Financials

Biomind Labs reported last fiscal year revenue of — and negative EBITDA of ($219K).

In the same fiscal year, Biomind Labs generated ($219K) in EBITDA losses and had net loss of ($260K).


Biomind Labs P&L

In the most recent fiscal year, Biomind Labs reported revenue of and EBITDA of ($219K).

Biomind Labs expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Biomind Labs forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
EBITDAXXX($219K)XXXXXXXXX
Net ProfitXXX($260K)XXXXXXXXX
Net Debt$671KXXXXXXXXX

Financial data powered by Morningstar, Inc.

Biomind Labs Stock Performance

Biomind Labs has current market cap of $6M, and enterprise value of $7M.


Biomind Labs' stock price is $0.08.

See Biomind Labs trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$7M$6M-0.3%XXXXXXXXX$-0.00

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Biomind Labs Valuation Multiples

Biomind Labs trades at (29.8x) EV/EBITDA.

See valuation multiples for Biomind Labs and 15K+ public comps

Biomind Labs Financial Valuation Multiples

As of March 28, 2026, Biomind Labs has market cap of $6M and EV of $7M.

Equity research analysts estimate Biomind Labs' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Biomind Labs has a P/E ratio of (22.6x).

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$6MXXX$6MXXXXXXXXX
EV (current)$7MXXX$7MXXXXXXXXX
EV/EBITDAXXX(29.8x)XXXXXXXXX
EV/EBITXXX(16.1x)XXXXXXXXX
P/EXXX(22.6x)XXXXXXXXX
EV/FCFXXX(18.4x)XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Biomind Labs Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Biomind Labs Margins & Growth Rates

Biomind Labs' revenue in the last fiscal year grew by .

See operational valuation multiples for Biomind Labs and other 15K+ public comps

Biomind Labs Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
EBITDA GrowthXXX(79%)XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Biomind Labs Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
AtonXXXXXXXXXXXXXXXXXX
ExpreS2ion BiotechXXXXXXXXXXXXXXXXXX
Pila PharmaXXXXXXXXXXXXXXXXXX
VivestoXXXXXXXXXXXXXXXXXX
GenxoneXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Biomind Labs M&A Activity

Biomind Labs acquired XXX companies to date.

Last acquisition by Biomind Labs was on XXXXXXXX, XXXXX. Biomind Labs acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Biomind Labs

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Biomind Labs Investment Activity

Biomind Labs invested in XXX companies to date.

Biomind Labs made its latest investment on XXXXXXXX, XXXXX. Biomind Labs invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Biomind Labs

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Biomind Labs

When was Biomind Labs founded?Biomind Labs was founded in 2020.
Where is Biomind Labs headquartered?Biomind Labs is headquartered in Uruguay.
How many employees does Biomind Labs have?As of today, Biomind Labs has over 3 employees.
Is Biomind Labs publicly listed?Yes, Biomind Labs is a public company listed on NEO Exchange.
What is the stock symbol of Biomind Labs?Biomind Labs trades under BMND ticker.
When did Biomind Labs go public?Biomind Labs went public in 2021.
Who are competitors of Biomind Labs?Biomind Labs main competitors are Aton, ExpreS2ion Biotech, Pila Pharma, Vivesto.
What is the current market cap of Biomind Labs?Biomind Labs' current market cap is $6M.
Is Biomind Labs profitable?No, Biomind Labs is not profitable.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial